Novo Nordisk 

Compound Sharing

Novo Nordisk 

Compound Sharing

||

Driving innovation through sharing


To accelerate innovation, Novo Nordisk openly shares novel peptide and protein analogues as well as antibodies for preclinical research.

Through this open innovation initiative, we offer easy and free access to selected high-quality and well-characterized compounds to curious and passionate scientists from around the world. We hope that sharing can advance the research of those who want to discover new mode of action and expand disease biology understanding, which can ultimately contribute to accelerating future breakthroughs for medical solutions.

The process and criteria are simple and transparent - we provide the compounds for free for you to validate your scientific hypothesis, you own the results and are encouraged to publish these. There is no reporting required but if you obtain exciting new results, you are welcome to get in touch for a discussion of the data and the possibilities for a future collaboration.



Available compounds

Explore and learn more about our compounds


Long-acting a-MSH analogue

NNC0070-0453

Read more

Long-acting amylin analogue

Coming soon

Read more

Long-acting CCK analogue

NNC0368-0056

Read more

Long-acting GLP-1 analogue #1

NNC0090-1170

Read more

Long-acting GLP-1 analogue #2

NNC0113-0217

Read more

Long-acting GLP-2 analogue

NNC0103-0147

Read more

Long-acting glucagon analogue

NNC9204-0043

Read more

Partial glucagonR agonist

NNC9204-1702

Read more

Small molecule glucagonR antagonist

NNC0025-0926

Read more

Long-acting insulin analogue

Coming soon

Read more

Liver-preferential insulin analogue

NNC0123-0327

Read more

InsR peptide antagonist (S961)

NNC0069-0961

Read more

PYY analogue - Y2 selective

NNC0165-1273

Read more

Long-acting PYY analogue

Coming soon

Read more

Anti-InsR mAb G6

NNC0276-3000

Read more

Anti-GLP-1R antibodies

mAb clone 7F38 and 3F52

Read more

Anti-IGF1R mAb 226

NNC0124-0226

Read more

 

 


About Novo Nordisk Compound Sharing

Watch the video below to learn more about Novo Nordisk Compound Sharing

 

If you have questions or comments in relation to Compound Sharing do not hesitate to contact us. You are also welcome to take a look at the FAQs.

You can reach us at compoundsharing@novonordisk.com – we are looking forward to answering your questions.

 

Tine Glendorf and Lars Linderoth
Scientists from the Novo Nordisk Compound Sharing team


Stay updated 


Be the first to know when we add new compounds to the site or stories related to how our compounds are being used in the scientific community 

 

Yes, I consent to receive Compound Sharing Updates from Novo Nordisk
I accept to have read and understood Novo Nordisk’s privacy notice. 
success icon Thank you for subscribing!
success icon

Careers in R&D

thumbnail

 

We are looking for scientific talent to join us. If you are interested in joining our research and development teams, explore your opportunities at our careers page.  
 

View R&D jobs

 

 

Partnering opportunities

thumbnail

 

Interested in partnering with Novo Nordisk? We constantly seek innovative alliances with academic and healthcare institutions, as well as leading biotechnology and pharmaceutical companies.


Partner with us